-
, the Netherlands. You will be employed by InnoSer and embedded in the POLARIS consortium, with academic supervision and disease-specific expertise provided by Dr Rogier Min at the Amsterdam Leukodystrophy Center
-
van Til at the Amsterdam Leukodystrophy Center (ALC). This doctoral project focuses on the preclinical assessment of gene therapy approaches in leukodystrophy mouse models for vanishing white matter
-
Centre for Preclinical Imaging, a leading preclinical imaging centre with access to advanced technologies including MRI, PET, CT, SPECT, ultrasound, photoacoustic imaging, magnetic particle imaging (MPI
-
-center clinical datasets and contribute to translating advanced computational methods into clinically relevant applications. This PhD position offers a unique opportunity to work at the intersection
-
closely with the Amsterdam Leukodystrophy Center at Amsterdam UMC and the Amsterdam UMC platform Medicijn voor de Maatschappij, a partner of RARE-NL. You will initiate and conduct several studies
-
on quality-of-life measurement or on risk and resilience research. You will develop your focus together with the research team. Planned secondments at the University of Oulu and the Anna Freud Centre will
-
partners in the Netherlands and abroad. You will work with large, multi-center clinical datasets and contribute to translating advanced computational methods into clinically relevant applications. This PhD
-
Within the Proteomics Core Resource at Amsterdam UMC, location VUmc, we are looking for a PhD candidate to join the recently funded NWA-ORC project META-IMMUNOTYPES – Decoding immune-metabolic
-
focus together with the research team. Planned secondments at the University of Oulu and the Anna Freud Centre will provide experience in digital quality-of-life assessment and psychosocial research. You